DUPILUMAB
dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes
DUPILUMAB (12316F)
12316F
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 2 | # of repeats: 5 | DPMQ: $1,658.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Dupixent | |||||